{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:28:32Z","timestamp":1790382512602,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jconrel.2023.07.025","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T15:14:00Z","timestamp":1690298040000},"page":"810-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice"],"prefix":"10.1016","volume":"360","author":[{"given":"Jooseppi","family":"Puranen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarja","family":"Haugas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Lingasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambet","family":"Teesalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Subrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Reinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.07.025_bb0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1479-5876-10-S1-S1","article-title":"Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery","volume":"10","author":"Li","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2017.05.054","article-title":"Vascular-homing peptides for cancer therapy","volume":"92","author":"Lu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/scbi.2000.0334","article-title":"Targeting tumor vasculature with homing peptides from phage display","volume":"10","author":"Ruoslahti","year":"2000","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0020","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration","volume":"106","author":"Teesalu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2013.12.006","article-title":"A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity","volume":"175","author":"Pang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0030","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(22)00167-4","article-title":"Dual \u03b1V-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study","volume":"7","author":"Dean","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0035","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ICU.0000000000000657","article-title":"Age-related macular degeneration therapy: a review","volume":"31","author":"Ammar","year":"2020","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","article-title":"Anti-vascular endothelial growth factor therapy for ocular neovascular disease","volume":"18","author":"Andreoli","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0050","article-title":"Photodynamic therapy with verteporfin (Visudyne)","volume":"41","author":"Bressler","year":"2000","journal-title":"Impact Ophthalmol. Visual Sci."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00006982-200208000-00001","article-title":"Photodynamic Therapy for Choroidal Neovascularization: a review","volume":"22","author":"Woodburn","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0060","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2147\/OPTH.S205147","article-title":"Predictors of visual acuity after treatment of neovascular age-related macular degeneration \u2013 current perspectives","volume":"15","author":"Phan","year":"2021","journal-title":"OPTH."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/vision2030031","article-title":"New therapies of neovascular AMD\u2014beyond anti-VEGFs","volume":"2","author":"Yerramothu","year":"2018","journal-title":"Vision"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41433-022-02020-7","article-title":"Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis","volume":"37","author":"Rosenberg","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00216","article-title":"Tumor-penetrating peptides","volume":"3","author":"Teesalu","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0085","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1038\/s41598-020-62760-y","article-title":"Tumor-penetrating peptide for systemic targeting of tenascin-C","volume":"10","author":"Lingasamy","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0090","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajo.2005.07.021","article-title":"Neuropilin-1 expression by endothelial cells and retinal pigment epithelial cells in choroidal Neovascular membranes","volume":"140","author":"Lim","year":"2005","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0095","first-page":"107","article-title":"Detection of tenascin-C in surgically excised choroidal neovascular membranes","volume":"238","author":"Nicol\u00f2","year":"2000","journal-title":"Clin. Invest."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0100","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/labinvest.2016.99","article-title":"Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin \u03b1V","volume":"96","author":"Kobayashi","year":"2016","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1167\/iovs.14-15589","article-title":"Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy","volume":"56","author":"Ishikawa","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/135164","article-title":"Integrin signaling as a Cancer drug target","volume":"2013","author":"Danen","year":"2013","journal-title":"ISRN Cell Biol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0115","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","article-title":"Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases","volume":"93","author":"Friedlander","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3129\/i08-145","article-title":"Expression of integrins in human proliferative diabetic retinopathy membranes","volume":"43","author":"Ning","year":"2008","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0125","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/iovs.63.9.11","article-title":"Animal models of choroidal neovascularization: a systematic review","volume":"63","author":"Fabian-Jessing","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109237","article-title":"Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection","volume":"224","author":"Puranen","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0140","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1021\/acs.molpharmaceut.9b00679","article-title":"Intravitreal pharmacokinetics in mice: SPECT\/CT imaging and scaling to rabbits and humans","volume":"16","author":"Schmitt","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169865","article-title":"Neuropilin 1 involvement in choroidal and retinal neovascularisation","volume":"12","author":"Fern\u00e1ndez-Robredo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0150","series-title":"ARVO Annual Meeting Abstract 46","article-title":"Integrin expression in laser\u2013induced CNV in mice: a microarray study","author":"Gamulescu","year":"2005"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0155","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1096\/fj.201700336R","article-title":"Animal models of ocular angiogenesis: from development to pathologies","volume":"31","author":"Liu","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/exer.1996.0219","article-title":"Retinal GFAP and bFGF expression after multiple argon laser photocoagulation injuries assessed by both immunoreactivity and mRNA levels","volume":"64","author":"Humphrey","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0165","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.87.4.488","article-title":"Laser photocoagulation alters the pattern of staining for neurotrophin-4, GFAP, and CD68 in human retina","volume":"87","author":"Ghazi-Nouri","year":"2003","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fnint.2017.00030","article-title":"Tenascins in retinal and optic nerve neurodegeneration","volume":"11","author":"Reinhard","year":"2017","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0175","first-page":"436","article-title":"Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy","volume":"22","author":"Kobayashi","year":"2016","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.642176","article-title":"Knock-out of tenascin-C ameliorates ischemia-induced rod-photoreceptor degeneration and retinal dysfunction","volume":"15","author":"Wiemann","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2023.07.025_bb0185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/pharmaceutics13040445","article-title":"Intravitreal polymeric nanocarriers with long ocular retention and targeted delivery to the retina and optic nerve head region","volume":"13","author":"Junnuthula","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.07.025_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121800","article-title":"Imaging, quantitation and kinetic modelling of intravitreal nanomaterials","volume":"621","author":"Sadeghi","year":"2022","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:53:57Z","timestamp":1759164837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923004492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":38,"alternative-id":["S0168365923004492"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.025","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}